NIFTY 50

Serum COVID vaccine safety concerns: Co threatens to countersue volunteer; experts seek transparency

Updated : November 30, 2020 04:41 PM IST

A 40-year-old trial participant has sued the Serum Institute of India (SII) alleging that the experimental vaccine caused a ‘severe adverse reaction’.
SII says the claims are malicious and misconceived.
The eerie silence from both the DCGI and the Drug Monitoring and Safety Board has added to the concerns on adherence to protocols and the overall safety of the vaccine.

You May Also Like

Live TV

recommended for you